Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$25.26 - $29.6 $293,016 - $343,360
11,600 New
11,600 $324,000
Q3 2023

Nov 03, 2023

BUY
$32.09 - $37.51 $709,189 - $828,971
22,100 New
22,100 $733,000
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $20.8 Million - $27.1 Million
-528,000 Reduced 68.32%
244,800 $9.99 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $22.6 Million - $29.5 Million
541,600 Added 234.26%
772,800 $39.6 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $11.3 Million - $13.8 Million
-257,600 Reduced 52.7%
231,200 $10.1 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $10.8 Million - $12.8 Million
232,400 Added 90.64%
488,800 $25.6 Million
Q1 2022

May 17, 2022

BUY
$45.75 - $56.69 $11.7 Million - $14.5 Million
256,400 New
256,400 $13.3 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $3.86 Million - $5.72 Million
-93,400 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $1.95 Million - $2.51 Million
-49,800 Reduced 34.78%
93,400 $4.02 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $3.99 Million - $4.52 Million
111,200 Added 347.5%
143,200 $5.56 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $1.07 Million - $1.21 Million
32,000 New
32,000 $1.16 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $19.6 Million - $23 Million
-616,200 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $5.46 Million - $6.62 Million
181,200 Added 41.66%
616,200 $20.2 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $5.99 Million - $8.56 Million
221,600 Added 103.84%
435,000 $14.2 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $7.03 Million - $7.97 Million
213,400 New
213,400 $8.36 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.